Developer docs
API playgroundTry for free, no card

Search company profiles

Veda Trials

Full company profile

uuid00pxvh8

Namestring
Veda Trials
Legal namestring
Veda Life Sciences, Inc.
Websiteurl
vedatrials.com
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Veda Trials (legal entity: Veda Life Sciences, Inc.) is a community-based clinical operations company founded in 2023 in Boston, Massachusetts. The company partners with community-based healthcare organizations and local providers to establish or enhance research operations, enabling end-to-end clinical trial execution in community care settings where broad patient populations can participate. Veda's core offering is a research enablement platform that streamlines site activation, reduces operational burden, and supports patient enrollment and data quality across decentralized clinical sites throughout the United States. The company's go-to-market is community-led and partnership-driven, with revenue generated through managed services (clinical operations support and technology access) provided to community clinics and, implicitly, to the trial sponsors whose studies are run at those sites.

Veda was originally backed by Redesign Health as its first institutional investor. On February 4, 2026, the company was acquired by Lightship Inc., a site-network and hybrid clinical trial delivery operator. Post-acquisition, Veda operates within Lightship's operations group, combining its community-based site network and operational platform with Lightship's broader site network, hybrid delivery model, and mobile research services. Founder and CEO Lesley Solomon continues in her role, reporting to Lightship CEO David MacMurchy. Near-term priorities focus on aligning SOPs across the combined entity and accelerating activation of existing Veda partner clinics. The company maintains a small team (1-10 employees) and serves community clinics and local providers as its primary customer base, with pharma, biotech, and life sciences trial sponsors as a secondary segment.

Short descriptiontext

Veda Trials is a community-based clinical operations company that partners with community healthcare organizations and local providers to run end-to-end clinical trials. Its research enablement platform streamlines site activation and reduces operational burden in decentralized community care settings across the United States.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBoston, United States
HQ citystring
Boston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
clinical trial operations, community-based research, clinical research enablement, site activation services, decentralized clinical trials
Industry3 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code3 codes
  • Services-Health Services8000
  • Services-Commercial Physical & Biological Research8731
  • Services-Management Consulting Services8742
Product category
Clinical Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Operations Services
TypeManaged Services
Description

Veda provides end-to-end clinical trial operations services to community-based healthcare organizations, enabling them to conduct clinical trials. Revenue is generated through service fees for research enablement, technology access, and operational support provided to partner clinics.

lightship.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Veda Trials provides end-to-end clinical trial operations services and a research enablement platform that allows community-based healthcare organizations and local providers to run clinical trials in their own care settings. The company's replicable model combines technology that streamlines site activation with operational support that reduces day-to-day trial execution burden, enabling broad and diverse patient populations to participate in clinical research.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Veda Trials offers a unified research enablement platform focused on end-to-end clinical trial operations. The company provides technology that enables community clinics and local providers to execute clinical trials by simplifying day-to-day trial execution and reducing operational burden. The core platform supports site activation, patient enrollment, and data quality maintenance across community-based clinical settings throughout the United States.

Product and service1 record
1Veda Trials Platform
CategoryClinical research enablement platform
Description

A research enablement platform that leads end-to-end clinical trial operations for community-based clinical sites, enabling community clinics and local providers to run trials through technology that streamlines site activation and reduces operational burden, supporting patient enrollment and data quality in local care settings.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Curavit is a fully decentralized clinical trial CRO focused on virtual and hybrid trial design and execution — directly comparable to Veda's DCT operating model and overlapping target customer base of pharma and biotech sponsors.

TypeDirect peer
Description

ObvioHealth is a DCT-focused CRO running fully decentralized and hybrid trials with integrated site services and technology — directly comparable to Veda in serving sponsors seeking non-traditional site execution models.

TypeEmerging player
Description

Medable provides a DCT technology platform (eCOA, eConsent, telehealth, remote monitoring) used by sponsors and sites to run decentralized trials — comparable as an enabling layer for community-based trial execution, though Medable is primarily software rather than site operations.

TypeDirect peer
Description

Javara operates an integrated clinical research site network embedded within community healthcare organizations, providing centralized infrastructure for community-based trials — directly aligned with Veda's community-clinic enablement model.

TypeBroad incumbent
Description

Velocity is a large multi-site clinical research organization operating dedicated research sites across the US — comparable as a site-network operator serving sponsors, though its model is purpose-built sites rather than community-clinic embedded.

TypeDirect peer
Description

Science 37 is a leading decentralized clinical trial operator delivering fully remote and hybrid trial execution through its site network and technology platform — directly comparable to Veda in enabling clinical research outside traditional site settings.

TypeBroad incumbent
Description

Clinipace is a mid-sized CRO offering clinical operations, site management, and biostatistics services to sponsors — comparable as a broader incumbent competitor for sponsor contracts that include site operations components.

TypeDirect peer
Description

Lightship is Veda Trials' parent company following the February 2026 acquisition, operating a hybrid and decentralized clinical trial site network with mobile research services — directly comparable operating model now extended with community-based clinics.

TypeBroad incumbent
Description

IQVIA is the largest global CRO with extensive site management organization (SMO) services and decentralized trial capabilities — comparable as a broad incumbent offering overlapping site operations and DCT services to pharma sponsors.

TypeDirect peer
Description

EmVenio (formed from the PCM Trials merger) operates community-based and mobile clinical research sites for decentralized trials — directly comparable to Veda's community-site model and overlapping sponsor customer base.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Veda Trials

Clinical Research Servicesvedatrials.com

Veda Trials is a community-based clinical operations company that partners with community healthcare organizations and local providers to run end-to-end clinical trials. Its research enablement platform streamlines site activation and reduces operational burden in decentralized community care settings across the United States.

What Veda Trials does

Veda Trials (legal entity: Veda Life Sciences, Inc.) is a community-based clinical operations company founded in 2023 in Boston, Massachusetts. The company partners with community-based healthcare organizations and local providers to establish or enhance research operations, enabling end-to-end clinical trial execution in community care settings where broad patient populations can participate. Veda's core offering is a research enablement platform that streamlines site activation, reduces operational burden, and supports patient enrollment and data quality across decentralized clinical sites throughout the United States. The company's go-to-market is community-led and partnership-driven, with revenue generated through managed services (clinical operations support and technology access) provided to community clinics and, implicitly, to the trial sponsors whose studies are run at those sites.

Veda was originally backed by Redesign Health as its first institutional investor. On February 4, 2026, the company was acquired by Lightship Inc., a site-network and hybrid clinical trial delivery operator. Post-acquisition, Veda operates within Lightship's operations group, combining its community-based site network and operational platform with Lightship's broader site network, hybrid delivery model, and mobile research services. Founder and CEO Lesley Solomon continues in her role, reporting to Lightship CEO David MacMurchy. Near-term priorities focus on aligning SOPs across the combined entity and accelerating activation of existing Veda partner clinics. The company maintains a small team (1-10 employees) and serves community clinics and local providers as its primary customer base, with pharma, biotech, and life sciences trial sponsors as a secondary segment.

Veda Trials firmographics

Firmographics
Name
Veda Trials
Legal name
Veda Life Sciences, Inc.
Website
https://vedatrials.com
Company type
Private
Founded year
2023
Operating status
Acquired
Headcount range
1–10 employees
Short description
Veda Trials is a community-based clinical operations company that partners with community healthcare organizations and local providers to run end-to-end clinical trials. Its research enablement platform streamlines site activation and reduces operational burden in decentralized community care settings across the United States.
Ownership category
akta.pro rank

Veda Trials industry classification

Industry
Product category
Clinical Research Services
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
SECONDARYHLAGACAD
Clinical Trial Patient Recruitment & Retention

Keywords

  • Clinical trial operations
  • Community-based research
  • Clinical research enablement
  • Site activation services
  • Decentralized clinical trials

Where Veda Trials is headquartered

Location

Headquarters

HQ city
Boston
HQ country
United States
HQ region
North America

Markets served

Veda Trials business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Clinical Operations Services: Veda provides end-to-end clinical trial operations services to community-based healthcare organizations, enabling them to conduct clinical trials. Revenue is generated through service fees for research enablement, technology access, and operational support provided to partner clinics.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Veda Trials product offering

Product offering

Core offering

Veda Trials provides end-to-end clinical trial operations services and a research enablement platform that allows community-based healthcare organizations and local providers to run clinical trials in their own care settings. The company's replicable model combines technology that streamlines site activation with operational support that reduces day-to-day trial execution burden, enabling broad and diverse patient populations to participate in clinical research.

Product overview

Veda Trials offers a unified research enablement platform focused on end-to-end clinical trial operations. The company provides technology that enables community clinics and local providers to execute clinical trials by simplifying day-to-day trial execution and reducing operational burden. The core platform supports site activation, patient enrollment, and data quality maintenance across community-based clinical settings throughout the United States.

Differentiator

Problem solved

Functional benefit

Products and services

  • Veda Trials Platform A research enablement platform that leads end-to-end clinical trial operations for community-based clinical sites, enabling community clinics and local providers to run trials through technology that streamlines site activation and reduces operational burden, supporting patient enrollment and data quality in local care settings.

Companies that use Veda Trials

Customer profile

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Veda Trials technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Veda Trials partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves4 records

Expansion highlights3 records

Veda Trials competitors and assessment

Company assessment

Direct peers

  • Curavit Clinical Research: Curavit is a fully decentralized clinical trial CRO focused on virtual and hybrid trial design and execution — directly comparable to Veda's DCT operating model and overlapping target customer base of pharma and biotech sponsors.
  • ObvioHealth: ObvioHealth is a DCT-focused CRO running fully decentralized and hybrid trials with integrated site services and technology — directly comparable to Veda in serving sponsors seeking non-traditional site execution models.
  • Javara Research: Javara operates an integrated clinical research site network embedded within community healthcare organizations, providing centralized infrastructure for community-based trials — directly aligned with Veda's community-clinic enablement model.
  • Science 37: Science 37 is a leading decentralized clinical trial operator delivering fully remote and hybrid trial execution through its site network and technology platform — directly comparable to Veda in enabling clinical research outside traditional site settings.
  • Lightship Inc. Lightship is Veda Trials' parent company following the February 2026 acquisition, operating a hybrid and decentralized clinical trial site network with mobile research services — directly comparable operating model now extended with community-based clinics.
  • EmVenio Research (PCM Trials): EmVenio (formed from the PCM Trials merger) operates community-based and mobile clinical research sites for decentralized trials — directly comparable to Veda's community-site model and overlapping sponsor customer base.

Emerging players

  • Medable: Medable provides a DCT technology platform (eCOA, eConsent, telehealth, remote monitoring) used by sponsors and sites to run decentralized trials — comparable as an enabling layer for community-based trial execution, though Medable is primarily software rather than site operations.

Broad incumbents

  • Velocity Clinical Research: Velocity is a large multi-site clinical research organization operating dedicated research sites across the US — comparable as a site-network operator serving sponsors, though its model is purpose-built sites rather than community-clinic embedded.
  • Clinipace Worldwide: Clinipace is a mid-sized CRO offering clinical operations, site management, and biostatistics services to sponsors — comparable as a broader incumbent competitor for sponsor contracts that include site operations components.
  • IQVIA: IQVIA is the largest global CRO with extensive site management organization (SMO) services and decentralized trial capabilities — comparable as a broad incumbent offering overlapping site operations and DCT services to pharma sponsors.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks6 records

Key highlights6 records

Customer concentration

Veda Trials social profiles

Digital presence

Veda Trials financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Veda Trials leadership team

Management profile

Number of profiles

Profiles1 record

Veda Trials funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Veda Trials M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veda Trials

What does Veda Trials do?

Veda Trials provides end-to-end clinical trial operations services and a research enablement platform that allows community-based healthcare organizations and local providers to run clinical trials in their own care settings. The company's replicable model combines technology that streamlines site activation with operational support that reduces day-to-day trial execution burden, enabling broad and diverse patient populations to participate in clinical research.

Is Veda Trials a public or private company?

Veda Trials is a private company. It is classified as corporate owned and is currently acquired.

When was Veda Trials founded?

Veda Trials was founded in 2023. It employs 1 to 10 people.

Where is Veda Trials based?

Veda Trials is headquartered in Boston, United States, in the North America region.

How does Veda Trials make money?

One revenue line is on record: clinical Operations Services.

Who are Veda Trials's main competitors?

Direct peers on record are Curavit Clinical Research, ObvioHealth, Javara Research, Science 37, Lightship Inc. and EmVenio Research (PCM Trials). Medable is listed as an emerging player. Broad incumbents are Velocity Clinical Research, Clinipace Worldwide and IQVIA.

Does Veda Trials have an API?

No public API is recorded for Veda Trials.

What industry is Veda Trials in?

Veda Trials's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 5417 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. announced the acquisition of Veda Trials, a company specializing in end-to-end clinical operations delivered in community care settings. The acquisition combines Veda's community-based operations model with Lightship's site network and mobile research services to expand reach into community clinics and accelerate enrollment for sponsors and health systems throughout the United States. Veda Trials will operate as part of Lightship's operations group, with integration priorities including aligning SOPs and training, and accelerating activation of existing Veda partner clinics.LightshipLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. announced the acquisition of Veda Trials, a company specializing in end-to-end clinical operations in community care settings, to strengthen its ability to reach diverse patient populations and accelerate trial enrollment across the United States. The deal combines Veda's community-based operations model with Lightship's site network, hybrid delivery model, and mobile research services to compress startup timelines and reduce operational burden for community clinics. Veda Trials, originally backed by Redesign Health as its first institutional investor, will operate as part of Lightship's operations group with Founder and CEO Lesley Solomon continuing in her role.GlobeNewswireLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. has acquired Veda Trials, a company specializing in end-to-end clinical operations in community care settings, with the transaction intended to strengthen Lightship's ability to reach representative participant populations and accelerate enrollment. Veda Trials, originally backed by Redesign Health, enables clinics and local providers to run clinical trials by simplifying day-to-day trial execution through technology that reduces operational burden. The combined entity will operate under Lightship's structure with Veda's Founder and CEO Lesley Solomon reporting to Lightship CEO David MacMurchy, and near-term priorities include aligning standard operating procedures and accelerating activation of existing Veda partner clinics.BioSpaceLightship Inc. Acquires Veda Trials to Expand Community-Based Clinical Research DeliveryLightship Inc. announced on February 4, 2026 the acquisition of Veda Trials, a company specializing in end-to-end clinical operations delivered in community care settings, expanding Lightship's ability to reach representative patient populations across the United States. Veda Trials, originally backed by Redesign Health, enables community clinics and local providers to run clinical trials through technology that streamlines site activation and reduces operational burden. The combined entity will offer sponsors unified operational playbooks, mobile research services, and flexible visit models including on-site, near-home, and in-home options to accelerate enrollment while maintaining data quality.